• Augustine, C.K., Jung, S.H., Sohn, I., Yoo, J.S., Yoshimoto, Y., Olson, J.A. Jr, Friedman, H.S., Ali-Osman, F., and Tyler, D.S. (2010). Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Mol. Cancer Ther. 9, 779790.
  • Conway, C., Mitra, A., Jewell, R. et al. (2009). Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin. Cancer Res. 15, 69396946.
  • Cookson, W., Liang, L., Abecasis, G., Moffatt, M., and Lathrop, M. (2009). Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184194.
  • Fidler, I.J., and Kripke, M.L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893895.
  • Harbst, K., Staaf, J., Masback, A., Olsson, H., Ingvar, C., Vallon-Christersson, J., Ringner, M., Borg, A., and Jonsson, G. (2010). Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Melanoma Res. 20, 381391.
  • Ravo, M., Mutarelli, M., Ferraro, L. et al. (2008). Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. Lab. Invest. 88, 430440.
  • Riker, A.I., Enkemann, S.A., Fodstad, O. et al. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 1, 13.
  • Turner, N., and Grose, R. (2010). Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116129.
  • Winnepenninckx, V., Lazar, V., Michiels, S. et al. (2006). Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl Cancer Inst. 98, 472482.